ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

NCI Advisory Board Approves Three Concepts

December 19, 2014

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003